Published in Oncogene on November 01, 1988
Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci U S A (1994) 2.25
Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Mol Cell Biol (1993) 2.08
Novel targets in non-small cell lung cancer: ROS1 and RET fusions. Oncologist (2013) 2.04
Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet (1994) 1.79
A human model for multigenic inheritance: phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus. Proc Natl Acad Sci U S A (2000) 1.76
Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol Cell Biol (1993) 1.64
Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet (2000) 1.61
Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. Nat Rev Clin Oncol (2009) 1.55
Formation of pseudosymmetrical G-quadruplex and i-motif structures in the proximal promoter region of the RET oncogene. J Am Chem Soc (2007) 1.53
Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest (1992) 1.52
Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis. Genes Dev (2001) 1.51
Structure and activity of the sevenless protein: a protein tyrosine kinase receptor required for photoreceptor development in Drosophila. Proc Natl Acad Sci U S A (1989) 1.50
Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol Cell Biol (1995) 1.44
Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene. EMBO J (1991) 1.28
Functional RET G691S polymorphism in cutaneous malignant melanoma. Oncogene (2009) 1.14
Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease. J Clin Invest (1998) 1.10
An epidermal growth factor receptor/ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway. Mol Cell Biol (1994) 1.07
The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease. BMC Cancer (2012) 1.07
Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification. Br J Cancer (2011) 1.03
Molecular heterogeneity of RET loss of function in Hirschsprung's disease. EMBO J (1996) 1.03
C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B. EMBO J (2000) 0.98
Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing. Am J Pathol (1994) 0.97
Hyperparathyroid genes: sequences reveal answers and questions. Endocr Pract (2011) 0.95
The Ret(C620R) mutation affects renal and enteric development in a mouse model of Hirschsprung's disease. Am J Pathol (2006) 0.94
Neuroblastoma in a transgenic mouse carrying a metallothionein/ret fusion gene. Br J Cancer (1993) 0.93
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. Proc Natl Acad Sci U S A (1996) 0.93
Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism. Mol Cell Biol (1998) 0.92
Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. Br J Cancer (1993) 0.91
Structure and physiology of the RET receptor tyrosine kinase. Cold Spring Harb Perspect Biol (2013) 0.90
Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2. Clinics (Sao Paulo) (2012) 0.89
The evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignature. Cancers (Basel) (2010) 0.88
Origin and diversification of TRIM ubiquitin ligases. PLoS One (2012) 0.88
Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. Am J Pathol (1995) 0.88
Thyroid cancer: current molecular perspectives. J Oncol (2010) 0.87
Purification and characterization of the human protein tyrosine phosphatase, PTP mu, from a baculovirus expression system. Mol Cell Biochem (1993) 0.86
Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation. Br J Cancer (1992) 0.86
Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements. Br J Cancer (2001) 0.85
Mapping of a novel MEN-like syndrome locus to rat chromosome 4. Mamm Genome (2004) 0.84
Solution structure of all parallel G-quadruplex formed by the oncogene RET promoter sequence. Nucleic Acids Res (2011) 0.83
Prognostic molecular biomarkers for cutaneous malignant melanoma. J Surg Oncol (2011) 0.82
Non-cell-autonomous effects of Ret deletion in early enteric neurogenesis. Development (2008) 0.81
Medullary thyroid carcinoma: molecular signaling pathways and emerging therapies. J Thyroid Res (2011) 0.81
A mutation in the RET proto-oncogene in Hirschsprung's disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B. Biochem J (1996) 0.80
Multiple endocrine neoplasias type 2B and RET proto-oncogene. Ital J Pediatr (2012) 0.80
RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material. Br J Cancer (1996) 0.79
[Molecular biology, basic research and diagnosis of Hirschsprung's disease]. Pathologe (2007) 0.78
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines. J Clin Invest (1992) 0.78
Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene. Langenbecks Arch Surg (2003) 0.77
Variations in the MHC region confer risk to esophageal squamous cell carcinoma on the subjects from high-incidence area in northern China. PLoS One (2014) 0.76
Rare manifestation of multiple endocrine neoplasia type 2A & cutaneous lichen amyloidosis in a family with RET gene mutation. Indian J Med Res (2014) 0.76
Molecular Diagnosis of Multiple Endocrine Neoplasia (MEN) in Paraffin-Embedded Specimens. Endocr Pathol (1995) 0.76
The RET proto-oncogene: a challenge to our understanding of disease pathogenesis. Pediatr Surg Int (1997) 0.75
Knockout mouse models of Hirschsprung's disease. Pediatr Surg Int (2015) 0.75
RET proto-oncogene mutations and rearrangements in endocrine diseases. Am J Pathol (1995) 0.75
The Clinical Relevance of Psammoma Body and Hashimoto Thyroiditis in Papillary Thyroid Carcinoma: A Large Case-control Study. Medicine (Baltimore) (2015) 0.75
Prognostic and Predictive Values of Subcellular Localisation of RET in Renal Clear-Cell Carcinoma. Dis Markers (2016) 0.75
A newly identified RET proto-oncogene polymorphism is found in a high number of endocrine tumor patients. Hum Genet (2005) 0.75
RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D. Oncotarget (2015) 0.75
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity (1999) 12.36
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature (2001) 11.03
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science (2001) 8.31
Transducing fragments in generalized transduction by phage P1. I. Molecular origin of the fragments. J Mol Biol (1965) 7.72
Prophage P1, and extrachromosomal replication unit. Cold Spring Harb Symp Quant Biol (1968) 4.75
Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1980) 4.66
Silencing factors participate in DNA repair and recombination in Saccharomyces cerevisiae. Nature (1997) 4.57
Genome sequence of an industrial microorganism Streptomyces avermitilis: deducing the ability of producing secondary metabolites. Proc Natl Acad Sci U S A (2001) 4.56
Changes in expression of murine leukemia virus antigens and production of xenotropic virus in the late preleukemic period in AKR mice. Proc Natl Acad Sci U S A (1976) 4.52
Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation (2001) 4.01
Persistent oxidative stress in cancer. FEBS Lett (1995) 3.85
Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest (1993) 3.57
Bloom's and Werner's syndrome genes suppress hyperrecombination in yeast sgs1 mutant: implication for genomic instability in human diseases. Proc Natl Acad Sci U S A (1998) 3.14
Relation of GIX antigen of thymocytes to envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.06
Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest (2000) 2.96
Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity (2000) 2.81
Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Antimicrob Agents Chemother (1994) 2.76
Experimental investigation of geologically produced antineutrinos with KamLAND. Nature (2005) 2.75
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. V. Identification of a new murine viral protein, p15(E). J Virol (1975) 2.72
RecQ DNA helicase is a suppressor of illegitimate recombination in Escherichia coli. Proc Natl Acad Sci U S A (1997) 2.51
Purification and characterization of DNA topoisomerase IV in Escherichia coli. J Biol Chem (1992) 2.50
Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer (1998) 2.48
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene. Antimicrob Agents Chemother (1996) 2.42
Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice. J Exp Med (1980) 2.38
Submucosal endoscopic tumor resection for subepithelial tumors in the esophagus and cardia. Endoscopy (2012) 2.32
Fractionated stereotactic radiotherapy for choroidal melanoma. Radiother Oncol (1997) 2.29
Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest (1997) 2.25
Developmentally regulated expression of a human "finger"-containing gene encoded by the 5' half of the ret transforming gene. Mol Cell Biol (1988) 2.21
Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes (1999) 2.19
Age-related changes in cell surface antigens of preleukemic AKR thymocytes. J Exp Med (1976) 2.15
Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood (1992) 2.06
A sharp peak of the zero-temperature penetration depth at optimal composition in BaFe2(As(1-x)P(x))2. Science (2012) 2.05
Production of 'hybrid' antibiotics by genetic engineering. Nature (1985) 2.04
Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation (1995) 2.02
High dose rate brachytherapy for carcinoma of the uterine cervix: comparison of two different fractionation regimens. Int J Radiat Oncol Biol Phys (1995) 2.02
A stable lead by modification of Sato's method. J Electron Microsc (Tokyo) (1986) 2.01
Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology (2008) 2.00
Illegitimate recombination mediated in vitro by DNA gyrase of Escherichia coli: structure of recombinant DNA molecules. Proc Natl Acad Sci U S A (1982) 1.97
Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay. Transfusion (2001) 1.97
Biological expression of antigenic determinants of murine leukemia virus proteins gp69-71 and p30. J Virol (1974) 1.95
Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation (2001) 1.92
Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol (1998) 1.91
In vitro study of illegitimate recombination: involvement of DNA gyrase. Cold Spring Harb Symp Quant Biol (1981) 1.90
Transgenic mouse model for skin malignant melanoma. Oncogene (1998) 1.90
Diversity of immunodominant 56-kDa type-specific antigen (TSA) of Rickettsia tsutsugamushi. Sequence and comparative analyses of the genes encoding TSA homologues from four antigenic variants. J Biol Chem (1992) 1.87
Characterization of a molecularly cloned retroviral sequence associated with Fv-4 resistance. J Virol (1985) 1.87
The rubble-pile asteroid Itokawa as observed by Hayabusa. Science (2006) 1.87
Serological survey of normal humans for natural antibody to cell surface antigens of melanoma. Proc Natl Acad Sci U S A (1980) 1.86
Ascorbic acid inhibits antitumor activity of bortezomib in vivo. Leukemia (2009) 1.84
Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci U S A (1987) 1.81
Fibulins: multiple roles in matrix structures and tissue functions. Cell Mol Life Sci (2009) 1.81
Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology (1989) 1.81
Quartz crystal microbalance for the detection of microgram quantities of human serum albumin: relationship between the frequency change and the mass of protein adsorbed. Anal Chem (1993) 1.73
Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro. Proc Natl Acad Sci U S A (1988) 1.70
Genetic mapping, cloning and physiological aspects of the glucose kinase gene of Streptomyces coelicolor. Mol Gen Genet (1984) 1.67
Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards. Lancet (1991) 1.66
Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens. Immunology (1994) 1.65
Changes in oropharyngeal airway and respiratory function during sleep after orthognathic surgery in patients with mandibular prognathism. Int J Oral Maxillofac Surg (2011) 1.64
Involvement of DNA-dependent RNA polymerase in a recA-independent pathway of genetic recombination in Escheria coli. Proc Natl Acad Sci U S A (1977) 1.63
Inflammatory pseudotumor of the liver: case report and review of the literature. J Pediatr Surg (2001) 1.61
Antimicrobial action of epsilon-poly-L-lysine. J Antibiot (Tokyo) (1984) 1.61
Cloning and sequencing of the gene (tsg56) encoding a type-specific antigen from Rickettsia tsutsugamushi. Gene (1990) 1.60
New mutant and congenic mouse stocks expressing the murine leukemia virus-associated thymocyte surface antigen GIX. J Exp Med (1975) 1.59
Benign conjunctival melanocytic lesions. Clinicopathologic features. Ophthalmology (1989) 1.59
Elastodysplasia and elastodystrophy as the pathologic bases of ocular pterygia and pinguecula. Ophthalmology (1983) 1.58
Immunoreactive alpha A crystallin in rat non-lenticular tissues detected with a sensitive immunoassay method. Biochim Biophys Acta (1991) 1.54
Transcription promotes recA-independent recombination mediated by DNA-dependent RNA polymerase in Escherichia coli. Proc Natl Acad Sci U S A (1979) 1.54
Quinone-induced oxidative stress elevates glutathione and induces gamma-glutamylcysteine synthetase activity in rat lung epithelial L2 cells. J Biol Chem (1994) 1.53
Effects of mutations of RAD50, RAD51, RAD52, and related genes on illegitimate recombination in Saccharomyces cerevisiae. Genetics (1996) 1.52
On the role of recA gene product in genetic recombination: an analysis by in vitro packaging of recombinant DNA molecules formed in the absence of protein synthesis. Mol Gen Genet (1978) 1.52
A unique sequence related to the ecotropic murine leukemia virus is associated with the Fv-4 resistance gene. Proc Natl Acad Sci U S A (1984) 1.51
Diagnosis of chronic liver disease from liver scintiscans by fuzzy reasoning. J Nucl Med (1995) 1.50
Clinical aspects of primary thyroid lymphoma: diagnosis and treatment based on our experience of 119 cases. Thyroid (1993) 1.49
The relationship between disturbed transit and dilated bowel, and manometric findings of dilated bowel in patients with duodenal atresia and stenosis. J Pediatr Surg (1997) 1.49
Moderate increase of mean daily temperature adversely affects fruit set of Lycopersicon esculentum by disrupting specific physiological processes in male reproductive development. Ann Bot (2006) 1.49
Targeted disruption of Na+/Ca2+ exchanger gene leads to cardiomyocyte apoptosis and defects in heartbeat. J Biol Chem (2000) 1.48
IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol (1994) 1.48
A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse. J Exp Med (1990) 1.48
DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol (1995) 1.48
Transducing fragments in generalized transduction by phage P1. 3. Studies with small phage particles. J Mol Biol (1965) 1.47
Double-strand break repair mediated by DNA end-joining. Genes Cells (1998) 1.47
Failure of ureteric bud invasion: a new model of renal agenesis in mice. Am J Pathol (2001) 1.47
Measurement of neutrino oscillation with KamLAND: evidence of spectral distortion. Phys Rev Lett (2005) 1.46
Cellular expression of murine leukemia virus gp70-related antigen on thymocytes of uninfected mice correlates with Fv-4 gene-controlled resistance to Friend leukemia virus infection. Virology (1983) 1.46
Anatomical, electrophysiological and pigmentary aspects of vision in the bush baby: an interpretative study. Vision Res (1965) 1.46
A new genetically obese-hyperglycemic rat (Wistar fatty). Diabetes (1981) 1.46
Elimination of both cell-free and cell-associated HIV infectivity in plasma by a filtration/methylene blue photoinactivation system. Transfusion (2000) 1.46
Glomerular crescent formation in renal amyloidosis. A clinicopathological study and demonstration of upregulated cell-mediated immunity. Clin Nephrol (2008) 1.45
Receptive field organization of 'sustained' and 'transient' retinal ganglion cells which subserve different function roles. J Physiol (1972) 1.45
Virus inactivation in hemoglobin solution by heat treatment. Artif Cells Blood Substit Immobil Biotechnol (2001) 1.44
P1-like plasmid in Escherichia coli 15. J Mol Biol (1970) 1.44
Results of bowel plication in addition to primary anastomosis in patients with jejunal atresia. J Pediatr Surg (2001) 1.43
PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells. Br J Haematol (1998) 1.43
Regulation of initiation of S phase, replication checkpoint signaling, and maintenance of mitotic chromosome structures during S phase by Hsk1 kinase in the fission yeast. Mol Biol Cell (2001) 1.42
Detection of GPIV (CD36) mRNA in Naka- platelets. Thromb Haemost (1991) 1.41
Chromosomal location and structure of the operon encoding peptide-chain-release factor 2 of Escherichia coli. Proc Natl Acad Sci U S A (1988) 1.41